Help make a difference...
|
Do you want to contribute to improving knowledge of medical conditions and treatments? Now and for the future? Taking part in one of our research studies may be for you. This can be a rewarding experience and can help you and others. Some studies give shopping vouchers as a thank you for your time. Taking part is always completely optional and you can opt out at any time. Our Pioneer research team can answer any questions. |
Pioneer Research Team
Who? |
What and Where? |
Dr Susie Cary |
Lead research GP. Based at Pioneer Bradgate but any Pioneer patient can speak to Dr Cary about research** |
Kat Placzek |
Research Admin based at Pioneer Medical Group |
**You don't need an appointment to speak to Dr Cary about research, please just either email us on bnssg.pmg@nhs.net or contact us online and Dr Cary will contact you back.
Active Studies
|
STOP (Successful Treatment of Paranoia)
Research Study Did you know? You can self-refer to the below study!
|
Trauma Informed Study
Did you know? You can self-refer to the below study!
|
Painful Diabetic Neuropathy Study
Did you know? You can self-refer to the below study!
The Active Brains Study
|
A new website called ‘Active Brains’ aims to help older adults to look after their brain and body health to prevent cognitive decline. The website supports older adults to make simple behavioural changes such as increasing physical activity, playing brain training games and finding ways to eat more healthily.
This study will trial the effectiveness and cost effectiveness of ‘Active Brains’. The trial will recruit two groups of older adults: 1) those with signs of cognitive decline 2) those without any cognitive decline |
|
Members of both of these groups will be randomly assigned to one of three trial groups: 1) care as they usually receive it from their GP practice, or 2) access to the Active Brains website, or 3) access to the Active Brains website plus brief support from a trained person (over the phone or by email). The trial will last for five years. At the end of the first year the study team will compare participants’ cognitive performance in each of the three study groups. After five years the study team will compare the three study groups again and will collect medical records data about diagnosis of dementia. The findings will reveal whether the Active Brains website is effective and cost-effective for older adults to avoid or delay cognitive decline.
Participant Eligibility Criteria:
Aged between 60 and 85 years old inclusive
Not have an existing diagnosis of dementia
Aged between 60 and 85 years old inclusive
Not have an existing diagnosis of dementia
Statement relating to COVID-19:
The vast majority of the recommendations made by the intervention can be carried out in or around an individual’s own home and in isolation from people outside of their own household. Importantly, activities recommended by the intervention are likely to offer benefits to older adults’ physical and mental wellbeing at a time where these are especially important for this demographic. Feedback from feasibility trial participants and PPI representatives indicated that the Active Brains recommendations are exactly the types of activity that many older adults would like to, and are able to, engage with at this time.
The vast majority of the recommendations made by the intervention can be carried out in or around an individual’s own home and in isolation from people outside of their own household. Importantly, activities recommended by the intervention are likely to offer benefits to older adults’ physical and mental wellbeing at a time where these are especially important for this demographic. Feedback from feasibility trial participants and PPI representatives indicated that the Active Brains recommendations are exactly the types of activity that many older adults would like to, and are able to, engage with at this time.
AvonCAP GP2
Clink image for study website
|
This study is about chest infections and worsening of asthma, COPD and heart failure. We want to understand: (a) what impact these illnesses have on patients and the NHS; (b) how many of these illnesses could be prevented by vaccination (e.g. with COVID vaccines and other vaccines that are being developed); and (c) what groups of patients might benefit most from vaccination. For patients who choose to take part, we will collect information (data) from their GP records about them and their illness; collect samples from their nose, throat, saliva and urine; and ask them to complete a diary about their symptoms and wellbeing. We will send participants “Love to Shop” vouchers to reimburse them for their time. Patients who are eligible to take part will be contacted by phone and, wherever possible, the study team will ask their permission to use their data.
|
Patients can choose to opt out – if they do, we will collect a small amount of non-identifiable data from their record (e.g. age, gender, qualifying condition, reason for opting out) so that we can compare them to patients who choose to take part. Sometimes, despite our efforts, we will be unable to contact the patient. To get a more complete picture of the number of chest infections, we would still like to include their information even without consent. We hold specific approval from the Health Research Authority’s Confidentiality Advisory Group for this. We are very careful to keep data confidential. The data will be anonymised - there will be no way of identifying the patient from the data. This study is led by researchers at the University of Bristol and is funded by Pfizer. For more information, please see the study website or contact the research team by email (bnssg.avoncapgp.pmg@nhs.net) or phone (0117 958 1405).
Pioneer has recruited an amazing 459 patients to this important study this year. Here is an update about the study.
AvonCAP GP2 - PRES Surveys |
|
|
AvonCAP GP2 is supported by the National Institute for Health and Care Research (NIHR), which funds and supports research in the NHS as well as public health and social care research. Part of the role of the NIHR is to improve research, so that people like you, who take part, have the best experience possible. We would value your feedback through this survey. Taking part in the survey is voluntary, you do not have to fill in this form. It generally takes up to five minutes to complete. Your answers will be used anonymously to help improve research. If you do complete the survey, please remember to add the name of the GP practice, where you took part in the research.
Please scan the QR code to be taken to PRES survey or click here to complete. |
|
|
TIGER study
Do you have a child 3 months to 2 years old who has eczema? Would you like to improve the treatment of eczema? If so, the TIGER study needs you!
We want to find out whether making changes to the diet of children with eczema, based on the results of food allergy tests, improves eczema control. If you are interested in taking part or would like to find out more, please contact the study team using the details below: Telephone: 0117 4553039 Email: tiger-study@bristol.ac.uk Website: www.bristol.ac.uk/eczema-allergy-study |
|
Join Dementia ResearchJoin Dementia Research is a service which allows anyone, with or without dementia, to register their interest in national dementia research. It helps people with dementia, their carers, or anyone interested in dementia research to be matched to studies. Signing up could make a real difference to you and others.
Please see the information leaflet for more information about this important service. |
Clinical Practice Research Datalink (CPRD)
|
Information in patient records is important for medical research to develop new treatments and test the safety of medicines. At Pioneer we support National medical research by sending some information anonymously from patient records to CPRD.
|
CPRD is a government organisation that provides anonymised patient data for research to improve patient and public health. You cannot be identified from the information sent to CPRD.
If you do not want anonymised information from your patient record to be used in research you can opt out by speaking to our practice manager or Dr Cary who leads research at the practice. For more information about how anonymised data is used please visit: www.cprd.com/public
If you do not want anonymised information from your patient record to be used in research you can opt out by speaking to our practice manager or Dr Cary who leads research at the practice. For more information about how anonymised data is used please visit: www.cprd.com/public
